| Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir P Labarga, P Barreiro, L Martin-Carbonero, S Rodriguez-Novoa, C Solera, ... Aids 23 (6), 689-696, 2009 | 343 | 2009 |
| Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients M Pérez-Olmeda, M Núñez, M Romero, J González, A Castro, JR Arribas, ... Aids 17 (7), 1023-1028, 2003 | 277 | 2003 |
| Viral hepatitis and HIV co-infection V Soriano, E Vispo, P Labarga, J Medrano, P Barreiro Antiviral research 85 (1), 303-315, 2010 | 273 | 2010 |
| Antiretroviral drugs and liver injury V Soriano, M Puoti, P Garcia-Gascó, JK Rockstroh, Y Benhamou, ... Aids 22 (1), 1-13, 2008 | 264 | 2008 |
| Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial M Núñez, C Miralles, MA Berdún, E Losada, K Aguirrebengoa, A Ocampo, ... AIDS research and human retroviruses 23 (8), 972-982, 2007 | 259 | 2007 |
| Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy P Barreiro, V Soriano, F Blanco, C Casimiro, JJ de la Cruz, ... Aids 14 (7), 807-812, 2000 | 232 | 2000 |
| Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients P Labarga, V Soriano, ME Vispo, J Pinilla, L Martín-Carbonero, ... The Journal of infectious diseases 196 (5), 670-676, 2007 | 225 | 2007 |
| Influence of 516G> T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects S Rodriguez-Novoa, P Barreiro, A Rendón, I Jiménez-Nacher, ... Clinical infectious diseases 40 (9), 1358-1361, 2005 | 217 | 2005 |
| Severe liver disease associated with prolonged exposure to antiretroviral drugs I Maida, M Núñez, MJ Ríos, L Martín-Carbonero, G Sotgiu, C Toro, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (2), 177-182, 2006 | 212 | 2006 |
| Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia S Rodríguez-Nóvoa, L Martín-Carbonero, P Barreiro, G González-Pardo, ... Aids 21 (1), 41-46, 2007 | 196 | 2007 |
| Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy V Soriano, C Dona, R Rodríguez-Rosado, P Barreiro, JG Lahoz Aids 14 (4), 383-386, 2000 | 177 | 2000 |
| Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz L Gallego, P Barreiro, R del Río, D González deRequena, ... Clinical Infectious Diseases 38 (3), 430-432, 2004 | 175 | 2004 |
| Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy P Barreiro, J del Romero, M Leal, V Hernando, R Asencio, C de Mendoza, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 43 (3), 324-326, 2006 | 168 | 2006 |
| Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations S Rodríguez-Nóvoa, P Labarga, A D'avolio, P Barreiro, M Albalate, ... Aids 24 (7), 1064-1066, 2010 | 164 | 2010 |
| Liver cirrhosis in HIV‐infected patients: prevalence, aetiology and clinical outcome C Castellares, P Barreiro, L Martín‐Carbonero, P Labarga, ME Vispo, ... Journal of viral hepatitis 15 (3), 165-172, 2008 | 161 | 2008 |
| Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir E Vispo, P Barreiro, JA Pineda, JA Mira, I Maida, L Martín-Carbonero, ... Antiviral therapy 13 (3), 429-438, 2008 | 154 | 2008 |
| Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C→ T polymorphism at the multidrug resistance gene 1 SR Nóvoa, P Barreiro, A Rendón, A Barrios, A Corral, I Jiménez-Nacher, ... Clinical infectious diseases 42 (2), 291-295, 2006 | 143 | 2006 |
| Management of chronic hepatitis B and C in HIV-coinfected patients V Soriano, P Barreiro, M Nunez Journal of Antimicrobial Chemotherapy 57 (5), 815-818, 2006 | 142 | 2006 |
| Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine A Barrios, A Rendón, E Negredo, P Barreiro, T Garcia-Benayas, ... Aids 19 (6), 569-575, 2005 | 137 | 2005 |
| Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin K Neukam, P Barreiro, J Macías, A Avellón, C Cifuentes, ... Clinical infectious diseases 57 (3), 465-468, 2013 | 135 | 2013 |
Vicente SorianoUNIR - Health Sciences School & Medical Center, Madrid, SpainDirección de correo verificada de unir.net
